Medicines / Reliance Life Science / Immunorel
ImmunorelHuman Normal Immunoglobulin
Immunorel is marketed by Reliance Life Science. 3 packs on NPPA's price list for July 2026, containing Human Normal Immunoglobulin.
- Packs listed
- 3
- Lowest MRP
- ₹2,017
- Per unit
- ₹201.66 to ₹269.76
- Price-controlled packs
- 2 of 3
- Dosage forms
- 2
Packs and prices
- ₹10,258Immunorel 5 % Infusion 50 mlHuman Normal Immunoglobulin Infusion 5 % · ₹205.16 per ml · price-controlled, ceiling ₹153.82 per ml
- ₹26,976Immunorel 10 % Infusion 100 mlHuman Normal Immunoglobulin Infusion 10 % · ₹269.76 per ml · price-controlled, ceiling ₹208.26 per ml
- ₹2,017Immunorel 5 % Injection 10 mlHuman Normal Immunoglobulin Injection 5 % · ₹201.66 per ml
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Human Normal Immunoglobulin Infusion 5 %
- ₹110.57/mlGammaren · 100 ml infusionIntas Pharmaceuticals · MRP ₹11,057 · price-controlled, ceiling ₹153.82 per ml
- ₹110.57/mlGlobucel · 100 ml infusionIntas Pharmaceuticals · MRP ₹11,057 · price-controlled, ceiling ₹153.82 per ml
2 other brands of this composition on the price list; the 2 lowest per ml are shown. All Human Normal Immunoglobulin packs
Human Normal Immunoglobulin Injection 5 %
- ₹156.03/mlGlobucel VF · 100 ml injectionIntas Pharmaceuticals · MRP ₹15,603
- ₹156.03/mlHuman IG · 100 ml injectionSamarth Life Sciences · MRP ₹15,603
- ₹180.98/mlEmglobulin · 100 ml injectionEmcure Pharmaceuticals · MRP ₹18,098
- ₹199.44/mlZyglob · 100 ml injectionZydus Healthcare · MRP ₹19,944
- ₹15,603/vialZygritha · 1 vial injectionGlenmark Pharmaceuticals · MRP ₹15,603
5 other brands of this composition on the price list; the 5 lowest per ml are shown. All Human Normal Immunoglobulin packs
The company
Reliance Life Science has 54 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.